News

The 'considerable reversal' in the fortunes of mid- and small-cap stocks seen since the start of March is likely to continue as large caps come back into favour, according to Jupiter's John Chatfeild-Roberts.

US pharmaceutical giant Pfizer has abandoned its plans to buy AstraZeneca following an unsuccessful pursuit of its UK rival.

Newly-launched boutique Sanditon Asset Management, formed by ex-Cazenove managers Tim Russell and Chris Rice, is poised to launch an investment trust within the next four weeks.

Lloyds Banking Group has announced plans to float a 25% stake in its TSB business next month in a bid to meet European rules on state aid for banks.

Mid-cap stocks have suffered a harsh and indiscriminate sell-off in recent weeks, and managers have pointed to liquidity concerns as a possible trigger for the falls.

Canada Life Investments is going head to head with absolute return giants by launching a new targeted volatility strategic fund, Investment Week can reveal.

A financial adviser has been jailed for three years after admitting 13 counts of theft from his pensioner clients.

A group of investors in troubled overseas property sales agent Harlequin has claimed a first victory in its battle to receive compensation from advisers who 'facilitated' their investments.

Aberdeen Asset Management has promoted Siddharth Dahiya to the newly created position of head of emerging market corporate debt following the departure of Esther Chan from the group.

The Financial Conduct Authority (FCA) has fined Barclays £26m for gold price fixing.